Cargando…

Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy

BACKGROUND: Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD). Cardiovascular (CV) complications are the most common cause of death among ESRD patients. Beraprost sodium (BPS) is a prostacyclin analog with vasodilatory and antiplatelet effects. METHODS: This is a multicente...

Descripción completa

Detalles Bibliográficos
Autores principales:	Na, Ki Young, Kim, Dong Ki, Kim, Sung Gyun, Lee, Young-Ki, Lim, Chun Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765998/ https://www.ncbi.nlm.nih.gov/pubmed/24066672 http://dx.doi.org/10.1186/1745-6215-14-275

Ejemplares similares

Effects of Beraprost Sodium on Subjective Symptoms in Diabetic Patients with Peripheral Arterial Disease
por: Yoon, Hang Seob, et al.
Publicado: (2013)

Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Correction to: Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Beneficial Effect of Beraprost Sodium Plus Aspirin in the Treatment of Acute Ischemic Stroke
por: Chen, Siqia, et al.
Publicado: (2017)

A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design
por: Nakamoto, Hidetomo, et al.
Publicado: (2014)

The Role of Systemic Arterial Stiffness in Open-Angle Glaucoma with Diabetes Mellitus
por: Shim, Seong Hee, et al.
Publicado: (2015)

Prospective analysis of the efficacy of beraprost sodium combined with alprostadil on diabetic nephropathy and influence on rennin-angiotensin system and TNF-α
por: Xu, Xinwei, et al.
Publicado: (2020)

Ultrasonography evaluation on the protective effect of combination therapy of beraprost sodium and aspirin on arteries occlusion and stiffness in patients with type 2 diabetes mellitus - a prospective, randomized study
por: Lin, Xian, et al.
Publicado: (2022)

Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria
por: Choi, Yun Mi, et al.
Publicado: (2019)

Ameliorative Effect of Beraprost Sodium on Celecoxib Induced Cardiotoxicity in Rats
por: Ahmad, Shafique, et al.
Publicado: (2018)

Vascular Endothelium as a Target of Beraprost Sodium and Fenofibrate for Antiatherosclerotic Therapy in Type 2 Diabetes Mellitus
por: Otsuki, Michio, et al.
Publicado: (2005)

Anastomotic leak after minimally invasive anterior resection for rectal cancer with high versus low ligation of the inferior mesenteric artery: a study protocol for a multicentre randomized clinical trial
por: Lee, Soo Young, et al.
Publicado: (2022)

A cohort evaluation on arterial stiffness and hypertensive disorders in pregnancy
por: Lim, Wai Yee, et al.
Publicado: (2012)

The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats
por: Peng, Li, et al.
Publicado: (2016)

Beraprost Sodium for Pulmonary Hypertension in Dogs: Effect on Hemodynamics and Cardiac Function
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Control of fluid balance guided by body composition monitoring in patients on peritoneal dialysis (COMPASS): study protocol for a randomized controlled trial
por: Baek, Seon Ha, et al.
Publicado: (2014)

Beraprost sodium protects against chronic brain injury in aluminum-overload rats
por: Pan, Yongquan, et al.
Publicado: (2015)

Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial
por: Baek, Seon Ha, et al.
Publicado: (2015)

Investigation of Beraprost Sodium on Cardiac Function and Hemodynamics in Canine Models of Chronic Pulmonary Hypertension
por: Suzuki, Ryohei, et al.
Publicado: (2022)

Clinical efficacy and safety of beraprost sodium in the treatment of nephrotic syndrome: A meta-analysis
por: Yan, Peng, et al.
Publicado: (2023)

Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial
por: Lee, Joo Myung, et al.
Publicado: (2013)

Pregabalin as an effective treatment for acute postoperative pain following spinal surgery without major side effects: protocol for a prospective, randomized controlled, double-blinded trial
por: Park, Ki-Hoon, et al.
Publicado: (2023)

Catalytic asymmetric formal synthesis of beraprost
por: Kobayashi, Yusuke, et al.
Publicado: (2015)

Arterial stiffness, fatty liver and the presence of coronary artery calcium in a large population cohort
por: Sung, Ki-Chul, et al.
Publicado: (2013)

Assessment of arterial stiffness, oxidative stress and inflammation in acute kidney injury
por: Fassett, Robert G, et al.
Publicado: (2009)

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Nephropathy
por: Kim, So Young, et al.
Publicado: (2018)

Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy
por: Lee, Su Mi, et al.
Publicado: (2015)

Safety and efficacy of PG102P for the control of pruritus in patients undergoing hemodialysis (SNUG trial): study protocol for a randomized controlled trial
por: Kim, Yong Chul, et al.
Publicado: (2019)

FRailty and Arterial stiffness – the role of oXidative stress and Inflammation (FRAXI study)
por: Mensah, Ekow, et al.
Publicado: (2022)

Increased Pulse Wave Velocity Reflecting Arterial Stiffness in Patients with Colorectal Adenomas
por: Lim, Yun Jeong, et al.
Publicado: (2010)

Effect of hypoxia and Beraprost sodium on human pulmonary arterial smooth muscle cell proliferation: the role of p27(kip1)
por: Kadowaki, Maiko, et al.
Publicado: (2007)

Evolocumab administration prior to Coronary Artery Bypass Grafting in patients with multivessel coronary artery disease (EVOCABG): study protocol for a randomized controlled clinical trial
por: Na, Hye Rim, et al.
Publicado: (2022)

The Prostacyclin Analog Beraprost Sodium Ameliorates Characteristics of Metabolic Syndrome in Obese Zucker (Fatty) Rats
por: Sato, Nahoko, et al.
Publicado: (2010)

Interleukin-10 Promoter Polymorphism is Associated with the Predisposition to the Development of IgA Nephropathy and Focal Segmental Glomerulosclerosis in Korea
por: Chin, Ho Jun, et al.
Publicado: (2005)

Effect of Bilirubin on Triglyceride Synthesis in Streptozotocin-Induced Diabetic Nephropathy
por: Xu, Jianwei, et al.
Publicado: (2014)

Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trial
por: Kang, Min-gu, et al.
Publicado: (2019)

The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trial
por: Park, Kyungil, et al.
Publicado: (2010)

Association of Arterial Stiffness and Osteoporosis in Healthy Men Undergoing Screening Medical Examination
por: Kim, Nam Lee, et al.
Publicado: (2014)

Cystatin C as an Early Biomarker of Nephropathy in Patients with Type 2 Diabetes
por: Jeon, Yun Kyung, et al.
Publicado: (2011)

Role of Nitric Oxide in the Pathogenesis of Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats
por: Choi, Ki Chul, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_i58turk192c3h6cmftt3ea2tsg